OCULAR HYPERTENSION
Clinical trials for OCULAR HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new OCULAR HYPERTENSION trials appear
Sign up with your email to follow new studies for OCULAR HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a second laser zap save your sight? new trial investigates
Disease control ENROLLING_BY_INVITATIONThis study looks at whether repeating a laser treatment (SLT) can safely lower eye pressure in people with glaucoma or high eye pressure. About 400 participants who already had one SLT will be followed and may get another laser if needed. The goal is to find the best way to repea…
Matched conditions: OCULAR HYPERTENSION
Phase: NA • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated May 26, 2026 04:21 UTC
-
Laser showdown: which glaucoma treatment works best?
Disease control OngoingThis study compares different ways of performing a laser treatment (SLT) for glaucoma to see which is safest and most effective at lowering eye pressure. About 400 adults with open-angle glaucoma, pseudoexfoliation glaucoma, or high eye pressure will be followed for three years. …
Matched conditions: OCULAR HYPERTENSION
Phase: NA • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated May 26, 2026 04:15 UTC
-
New eye injection could ease glaucoma pressure
Disease control OngoingThis study tests an experimental drug injection (AGN-193408 SR) in 100 adults with open-angle glaucoma or high eye pressure. The goal is to see if it safely lowers eye pressure, which is the main way to control these conditions. Participants stop their usual eye drops during the …
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE1, PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated May 26, 2026 04:14 UTC
-
Laser breakthrough for glaucoma in chinese patients?
Disease control OngoingThis study tests a laser treatment called Direct Selective Laser Trabeculoplasty (DSLT) in 40 ethnic Chinese people with glaucoma or high eye pressure. The goal is to see if it safely lowers eye pressure over 6 to 12 months. Participants must have mild to moderate disease and be …
Matched conditions: OCULAR HYPERTENSION
Phase: NA • Sponsor: BelkinVision • Aim: Disease control
Last updated May 26, 2026 04:13 UTC
-
New eye drop shows promise for glaucoma patients in china
Disease control OngoingThis study tests a new eye drop called DE-117B for people with open-angle glaucoma or high eye pressure. It aims to see if the drops safely lower eye pressure over time. About 345 adults in China will use the drops daily for at least 4 weeks, with some receiving an active compara…
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE3 • Sponsor: Santen Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 04:12 UTC
-
New implant could control glaucoma for years after cataract surgery
Disease control OngoingThis study follows 23 people who received a special lens implant that slowly releases glaucoma medication during cataract surgery. Researchers want to see if the implant keeps eye pressure low and vision clear for up to 7 years. Participants already completed an earlier study and…
Matched conditions: OCULAR HYPERTENSION
Sponsor: SpyGlass Pharma, Inc. • Aim: Disease control
Last updated May 18, 2026 12:12 UTC